8-K
filed June 23, 2023, 7:59 PM ET
ticker RCKT
CIK 0001281895
other
confidence high
sentiment neutral
materiality 0.10
Rocket Pharma shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting
ROCKET PHARMACEUTICALS, INC.
- Nine directors elected; average support ~97% of votes cast (excluding broker non-votes).
- EisnerAmper LLP ratified as independent auditor for FY 2023 with 70.8M for, 901.6K against.
- Non-binding say-on-pay approved: 53.8M for, 10.5M against, 18.4K abstentions.
- Meeting held June 22, 2023; ~89% of outstanding shares represented.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ROCKET PHARMACEUTICALS, INC. shareholders approved Election of Directors at the 2023-06-22 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
The Company’s stockholders approved the election of nine directors to the Company’s Board of Directors (“Board”) by the following votes:
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ROCKET PHARMACEUTICALS, INC. shareholders approved Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2023-06-22 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement for the 2023 Annual Meeting of Stockholders pursuant to Section 14A of the Exchange Act, including the Compensation Discussion and Analysis, the Summary Compensation Table, and the narrative disclosures that accompany the compensation tables. The final votes were:
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ROCKET PHARMACEUTICALS, INC. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-06-22 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-22
Exact text from the filing
The Company’s stockholders ratified the appointment of EisnerAmper LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2023 by the following votes:
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.